Human immunodeficiency virus type 1 Nef down-regulates surface expression of murine and human CD4 but not human CD8. We recently reported that the cytoplasmic domain of CD4 is required for its down-regulation by Nef. Using a chimeric molecule composed of the extracellular and transmembrane domains of human CD8 fused to the cytoplasmic domain of human CD4, we show here that the cytoplasmic domain of CD4 is sufficient for down-regulation by Nef. Since the cytoplasmic domain of CD4 is also the site of its association with p561ck, we used a series of CD4 mutants to determine whether the regions of the cytoplasmic domain of CD4 required for down-regulation by Nef are the same as those required for p56"ck binding. Our results indicate that the portion of the cytoplasmic domain required for the down-regulation of CD4 by Nef overlaps with the binding site of p56kk, but the cysteine residues which are essential for the association of CD4 with p561ck are not required. This observation raised the possibility that Nef competes with p56lck for binding to CD4. However, under conditions which are considerably milder than those permissive for coimmunoprecipitation of CD4 and p561, we found no evidence for an association between Nef and CD4. While a decrease in total CD4 was observed in lysates of cells expressing Nef, the levels of p56vk were not significantly affected. Pulse-chase experiments further revealed a decrease in the half-life of CD4 in Nef-expressing cells. These results show that the decrease in surface CD4 expression induced by Nef is mediated at least in part by a decrease in the half-life of CD4 protein. These results also indicate that a large portion of p561ck is free of CD4 in T cells expressing Nef, which could have a significant effect on T-cell function.
CD4 is the major cell surface receptor for human immunodeficiency virus (HIV) (15, (32) (33) (34) 36) and is an important molecule for T-cell activation (30, 41) . Macrophages and T cells infected with HIV in vitro have reduced surface CD4 expression (15, 19, 22, 26, 43, 49) . The reduction in surface CD4 expression is due at least in part to the interaction between the HIV envelope protein gpl60 and CD4 in the cytoplasm of the infected cell (13, 29, 48) together with the auxiliary effect of Vpu (58, 59) . Work from our laboratory and others has demonstrated that the expression of HIV or simian immunodeficiency virus Nef in CD4+ cells also suppresses the expression of both mouse and human CD4 at the cell surface (5, 7, 20, 21, 24, 35) . The down-regulation of surface CD4 expression is a property of Nef both from laboratory strains and clinical isolates of HIV-1 (5, 7, 35) .
The mechanism by which Nef suppresses CD4 expression still is not known. We recently reported that the cytoplasmic domain of human CD4 is required for its down-regulation by Nef (20) . The cytoplasmic domain is highly conserved between mouse and human CD4, sharing 79% identical residues (41) , and is the site of association with the Src family tyrosine kinase p56Ick (42, 52) . Activation of p56 ck via engagement of CD4 at the cell surface is critical for antigen-driven stimulation of T cells through the CD3/T-cell receptor complex (12, 23, 50) . The purpose of the present study was to determine whether the cytoplasmic domain of CD4 is sufficient for its down-regulation by Nef and whether the regions of the cytoplasmic domain required for Nef-mediated down-regulation are the same as those required for the association of CD4 with p561ck. We have examined the effect of Nef on the surface expression of (i) a chimeric molecule composed of the extracellular and transmembrane domains of human CD8 and the cytoplasmic domain of human CD4 and (ii) a series of murine CD4 molecules containing truncations or mutations within the cytoplasmic tail which affect their association with p56Ick (51) . Our results show that the cytoplasmic domain of CD4 is both necessary and sufficient for down-regulation by Nef and that the region of the cytoplasmic domain required for down-regulation overlaps the residues involved in the association of CD4 with p56Ick.
Furthermore, the reduced levels of CD4 at the cell surface correlate with a reduction in steady-state levels of CD4 protein and a decrease in the half-life of CD4 in cells expressing Nef.
MATERIALS AND METHODS
Construction of the human CD8/CD4 chimeric expression vector. The chimeric human CD8/CD4 construct SV-884 was generated by overlapping PCR, resulting in an in-frame hybrid coding sequence with a junction between amino acid 186 of human CD8 and amino acid 398 of human CD4. The chimeric protein is composed of the extracellular and transmembrane domains of human CD8 fused to the cytoplasmic domain of human CD4 (Fig. IA) . The CD8 and CD4 fragments were amplified separately, mixed, and reamplified with external primers containing a 5' EcoRI site and a 3' XbaI site. The full-length PCR XbaI and cloned into the pSV-7d expression vector (33) to generate pSV-884.
Cell lines and culture conditions. The human T-cell lines HPB-ALL/LN and HPB-ALL/LNefSN and the human monocytic cell lines U937/LN and U937/LNefSN, transduced to express the neomycin phosphotransferase gene (Neor) only or HIV-lsF2 Nef and Neor, have been described previously (21) . The AKR1-G1/LN and AKR1-G1/LNefSN murine T-cell lines (20) and HuT-78 human T cells expressing Neor or two different primary isolates of HIV-1 Nef (233 and 248) have also been described elsewhere (5) . Murine L cells expressing wildtype murine CD4 (L3T4) (20) and L3T4 cDNA expression vectors (51) were generously provided by D. Littman (University of California, San Francisco). NIH 3T3 TK-cells expressing the murine CD4 mutants were generated by retrovirusmediated gene transfer as described previously (20) . Cells expressing murine CD4 on their surface were selected by fluorescence-activated cell sorting (FACS) as described below. Cells expressing the human CD8/CD4 chimeric molecule (see above and Fig. 1A ) were generated by cotransfection of NIH 3T3 TK-cells with pSV884 and a thymidine kinase expression plasmid as described previously (37) .
All human cell lines were cultured in RPMI 1640 medium with 25 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES) supplemented with 10% fetal bovine serum (HyClone, Logan, Utah), penicillin and streptomycin (50 IU and 50 ,ug/ml, respectively), 2 mM L-glutamine, and 1 mM sodium pyruvate (RPMI complete medium). The human cell lines were maintained at 37°C in a humidified incubator with 5% CO2. The murine L cells, NIH 3T3 TK-cells, and AKR1-G1 cells were cultured in Dulbecco modified Eagle medium with 10% fetal bovine serum and penicillin-streptomycin at 37°C in a humidified incubator with 10% CO2.
Retrovirus-mediated transduction of HIV-1 nef. The control retroviral vectors LN and LXSH and the Nef expression vectors LNefSN and LNefSH were generated as previously described (20, 38, 39) . Briefly, virus-containing supernatants were harvested from confluent plates of PA317 producer cells, filtered (0.45-,um-pore-size filter), and stored at -70°C. For transduction, the cells of interest were infected by overnight incubation with virus-containing supernatants and selected in hygromycin B (200 ,ug/ml) or G418 (1.5 mg/ml), using standard methodology as described previously (5, 20, 21 of SDS-PAGE sample buffer. For experiments with digitonin, cells were lysed in buffer containing 1% digitonin (Sigma Chemical Co., St. Louis, Mo.) in place of NP-40 and immunoprecipitated as described above. All washes were also performed with digitonin in place of NP-40.
The precipitates were separated on SDS-12% polyacrylamide gels and analyzed for the presence of Nef, p56 k, and human CD4 by Western blotting. The Western blotting protocol was essentially as described above except that 125I-protein A (Amersham catalog no. IM.144), 0.2 puCi per blot, was used in place of the secondary antibody, and development was by autoradiography. The rabbit anti-human CD4 antiserum (T4-4) has been described previously (17) 
RESULTS
The cytoplasmic domain of CD4 is sufficient for downregulation by Nef We reported previously that the cytoplasmic domain of CD4 is necessary for down-regulation by Nef (20) . To further determine whether the CD4 cytoplasmic domain is sufficient for down-regulation by Nef, we took advantage of our previous observation that expression of human CD8 is not affected by Nef (20 (Fig. 1B) . Analysis of surface expression of the chimeric CD8/CD4 molecule by FACS shows that this molecule is efficiently down-regulated by Nef (Fig. 1C) . Our previous results showed that neither human CD8 nor a chimeric molecule with the extracellular domain of human CD4 and the cytoplasmic and transmembrane domains of human CD8 was affected by Nef (20) . Together with the data presented here, these results demonstrate that the cytoplasmic domain of CD4 is both necessary and sufficient for down-regulation by Nef.
The p56kk binding domain of CD4 overlaps but is different from the region required for cell surface down-regulation by Nef. Since the cytoplasmic domain of CD4 is also the site of its association with p56Ick, we proceeded to determine whether the region of the CD4 cytoplasmic domain required for down-regulation by Nef is the same as that required for p561ck
binding. The residues in the cytoplasmic domain of CD4 involved in the association with p56k were mapped previously, using a series of mutated murine CD4 molecules (51). Since Nef is able to down-regulate both murine and human CD4 under similar conditions (5, 21), we used this well-characterized set of murine CD4 mutants to determine whether the requirements for binding to p561ck are the same as those required for down-regulation by Nef. Figure 2A shows a diagram of the murine CD4 mutants and their association with p56 Ik (adapted from Turner et al. [51] ). Mutants Ti, T2, and T3 are truncation mutants lacking the C-terminal 34, 23, and 10 amino acids of the cytoplasmic domain, respectively. In addition, we tested the mutant MCA1/2, in which the two cysteine residues critical for p561k association are substituted with alanines, and A412, which has a deletion of 18 amino acids within the membrane-proximal portion of the cytoplasmic domain. Of these, only CD4 T3 was able to associate with p561ck (51) . Murine L cells expressing wild-type murine CD4 or NIH 3T3 cells expressing the CD4 mutants were transduced with LNefSH or with a control vector (LXSH) in parallel. Transduced cells then were selected in medium containing hygromycin and analyzed for Nef expression by Western blotting. In all cases, we analyzed cell populations rather than individual clones. As shown in Fig. 2B , all of the cell lines transduced with LNefSH express HIV-lsF2 Nef. In contrast, no Nef was detected in cells transduced with the control vector LXSH.
To determine which mutant CD4 molecules were downregulated by Nef, the Nef-expressing and control cells were analyzed for surface expression of CD4 by flow cytometry. The data in Fig. 3 are representative of at least two independent experiments for each CD4 mutant. As shown in Fig. 3A , wild-type murine CD4 was efficiently down-regulated by Nef in L cells, in agreement with our previous results (20) . The significant degree of wt CD4 down-regulation occurred despite lower levels of Nef expression (Fig. 2B) (Fig. 3) . Thus, for the deletion and truncation mutants of murine CD4, the sensitivity to down-regulation by Nef correlates with the ability to associate with p56lck. However, this correlation does not hold for the mutant MCA1/2. This mutant lacks by substitution the cysteine residues which are critical for the association of CD4 with p561ck (51) . It does, however, produce a full-length CD4 molecule. Despite its failure to associate with pS6Ick, MCA1/2 is significantly downregulated by Nef (Fig. 3F) .
Thus, of the CD4 mutants described above, only T3 and MCA1/2 showed significant down-regulation by Nef. All other CD4 mutants were unaffected or minimally affected despite similar levels of Nef expression. These results indicate that the binding site for p56 ck overlaps the region of CD4 required for down-regulation by Nef but is different in that the cysteine residues critical for the CD4-p56Ick binding are not required for Nef-induced down-regulation.
Failure to coimmunoprecipitate Nef and CD4. The results described above and the similarities between p56Ick and Nef suggested that Nef might interact directly with CD4 in a manner similar to p561c and in so doing displace p561ck from its association with CD4. Therefore, we investigated the possibility of an association between Nef and CD4 by coimmunoprecipitation under conditions significantly milder than those in which CD4-p56lck coprecipitation has been observed (3, 42, 52 anti-serum in Western blots (Fig. 4A, top) . Likewise, the anti-Nef antiserum precipitated Nef (Fig. 4A, middle) . However no Nef was detected in CD4 immunoprecipitates, nor did we detect CD4 in Nef immunoprecipitates. Under the same conditions, p561ck was detected in anti-CD4 immunoprecipitates (Fig. 4A, bottom) but not in the anti-Nef precipitates.
Because the interaction between CD4 and Nef might be disrupted by NP-40, we performed parallel experiments in which the cells were lysed in 1% digitonin instead of NP-40. As expected, we were able to demonstrate an association between CD4 and p56ckk by coimmunoprecipitation in digitonin lysates of HPB-ALL/LNefSN cells (Fig. 4B, top and bottom) . However, we were unable to detect any association of CD4 with Nef in the digitonin lysates of HPB-ALL/LNefSN cells with this technique (Fig. 4B, top and middle) . Thus, we found no evidence for a physical association between Nef and CD4 by coimmunoprecipitation under conditions in which the association of CD4 and p56/Ck is demonstrated. Furthermore, a significant amount of the residual CD4 in HPB-ALL cells expressing Nef is still associated with p561kc (Fig. 4) Figure 5A to C show that surface CD4 expression was lower in HPB-ALL, U937, and HuT-78 cells expressing Nef than in cells transduced with the control vector LN. Total CD4 and total p56/c/ levels in these cells were determined by Western blot analysis of whole lysates (Fig.SD) and quantified by computerized image analysis of 1251 autoradiographs (Table 1) . In all cell lines tested, there was a Nef isolate is from HIV-1sF2 for HPB-ALL and U937 cells and from two primary isolates of HIV-1 (233 and 248, [5] (Fig. 5D, top (Table 1 ). In contrast, the decrease in pS6lk levels in HPB-ALL cells expressing Nef was about 50% compared with the LN control cells, and in HuT-78 cells, the p561ck levels were slightly higher in cells expressing Nef (Fig. 5D, bottom ; Table  1 ). U937 cells do not express any p561ck and therefore served as a negative control for p56lck (Fig. 5D, bottom) (42, 45, 51, 52) . The engagement (cross-linking) of CD4 at the T-cell surface is a crucial event in T-cell activation (12, 23, 50, 53, 54) . Our results indicate that the cytoplasmic domain of CD4 is sufficient for down-regulation by Nef and that the domain required for down-regulation overlaps the site of association with p56lck (45, 51) . However, the two cysteine residues which are essential for association with p561ck are not required for down-regulation by Nef (21) and requires the cytoplasmic domain of CD4 (20) suggests that the effect of Nef on CD4 is both posttranscriptional and posttranslational. CD4 is down-regulated from the surface of mouse and human T cells following exposure to phorbol es'ters such as phorbol myristate acetate (PMA) (1, 4, 8, 18, 27, 31, 46, 56) . PMA activates protein kinase C, which in turn phosphorylates three serine residues in the cytoplasmic domain of CD4. This phosphorylation leads to the internalization and subsequent degradation of CD4 (8, 18, 27, 46) . Mutant CD4 molecules in which the serine residues have been substituted with alanines are no longer sensitive to down-regulation by PMAk (18, 46) Dissociation of p56Ick from CD4 accompanies or is required for the down-regulation of CD4 by PMA (28, 47) . In contrast, Nef is able to suppress the expression of CD4 in B-cell, monocytic, and fibroblast cell lines which do not express pS6Ick (20, 21) as well as in T-cell lines. Thus, the ability of Nef to down-regulate CD4 is neither dependent on nor inhibited by the presence of p561ck. Instead, it is likely that the residual CD4 expressed on the surface of Nef-expressing T cells has escaped the action of Nef and is able to associate with p56lck (Fig. 4) .
In a previous study, we failed to observe a significant decrease in total CD4 protein in HPB-ALL/LNefSN cells by immunoprecipitation of metabolically labeled CD4 (21) (Fig. 5) , and suggest a lack of intracellular accumulation of CD4 in cells expressing Nef. Results of pulse-chase experiments using improved methods for immunoprecipitation revealed an increase in CD4 degradation in U937/LNefSN cells compared with the U937/LN control cells. These results are consistent with either an increase in endocytosis of fully mature CD4 molecules from the cell surface and subsequent degradation of the internalized CD4 or with degradation of CD4 molecules before they reach the cell surface. Experiments to distinguish between these two possibilities are currently in progress.
Expression of HIV envelope protein (gpl60) in CD4' cells inhibits expression of CD4 at the cell surface (13, 29, 48) . CD4-gpl6O complexes form in the endoplasmic reticulum and Golgi complex and are subsequently degraded in lysosomes (13, (57) (58) (59) . Degradation of CD4 is further enhanced in the presence of Vpu (58, 59) and also occurs in vitro in the presence of Vpu alone (11, 55) . Thus Env, Vpu, and Nef provide HIV with three different mechanisms by which it can suppress the expression of its cell surface receptor, CD4. The nef gene is expressed early after infection, while env and vpu are expressed later, as mature virions are forming (14) . It has been postulated that suppression of CD4 expression is beneficial to the virus by preventing superinfection (7, 21) and by promoting shedding of the virus from infected cells (7) .
Infected T cells with reduced levels of surface CD4 also would be expected to be less susceptible to envelope-dependent fusion with other infected cells (7, 21, 48) or to the possible toxic effects of soluble gpl20 (6) . A reduction in CD4 expression caused by Nef might also affect the activation and function of T cells by altering the levels or distribution of pS65ck. It is estimated that up to 95% of p561ck is associated with CD4 in T cells and T-cell lines (25, 28 (2, 9, 10, 40) , probably involving p56lck (16, 44) . Observations by Haughn et al. (25) suggest that cells lacking CD4 and grown in the continuous presence of interleukin-2 (IL-2) (e.g., T-cell clones) receive compensatory p56 Ik signaling through the IL-2 receptor and thus maintain normal responsiveness to anti-T-cell receptor stimulation. This situation could have important consequences for host-virus interactions at the cellular level by altering T-cell responses to antigenic stimulation. In the absence of normal CD4 signaling, an association of p56lck with other signal-transducing receptor molecules, such as CD2 or the IL-2 receptor, might maintain the ability of T cells to respond to external stimuli. In this way, the HIV-infected cell, with lower levels of CD4, could still be activated and thereby replicate virus. HIV has three different mechanisms to suppress CD4 expression. As indicated above, only Nef is expressed early after infection. The significance of this receptor down-regulation mechanism for in vivo virus spread and pathogenesis remains to be elucidated.
